Aeon Biopharma inc (AEON) Annual Balance Sheets

Annual · GAAP · USD millions
Access AEON quarterly Balance Sheets →
Quarterly balance sheet trends provide context on Aeon Biopharma inc's liquidity, leverage, and long-term financial structure.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent3.01
Cash & Short-term Investments3.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.39
Total Current Assets3.40
Equipment/Property/Plant Net0.16
Deferred, Prepaid and Other Assets, Noncurrent0.00
Other Assets, Noncurrent2.00
Operating Lease Right Of Use Asset1.05
Total Assets5.56
Liabilities
Accounts Payable, Current AC0.94
Employee-related Liabilities, Current AC2.87
Other Liabilities, Current3.08
Sales and Excise Tax Payable, Current0.00
Total Current Liabilities6.90
Convertible Notes Payable, Noncurrent LO34.60
Total Long-term Debt34.60
Derivative Liability, Noncurrent DE14.88
Other liabilities, Noncurrent4.21
DeferredUnderwritingCompensationsNoncurrent-
Accrued Clinical Trails Expenses Current1.43
Operating Lease Liability Noncurrent0.89
Total Liabilities60.59
Stockholders' Equity
Subscription Receivables-
Common Stock Value0.01
Additional Paid In Capital Common Stock415.78
Retained Earnings / Accumulated Deficit-470.82
Defined Benefit Plan and Other3.28
Other Equity-3.28
Common Stockholder's Equity-55.03
Non-controlling interests & other0.00
Total Stockholder's Equity-55.03
Liabilities & Stockholder's Equity5.56
4 historic quarters locked

Sign in to unlock the full Aeon Biopharma inc balance sheet history.

About Aeon Biopharma Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001837607-26-000019

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License